MCM
TSVT

Monimus Capital Management’s 2seventy bio TSVT Stock Holding History

Monimus Capital Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-296,260
Closed -$1.46M – 63
2025
Q1 		$1.46M Buy
296,260
+32,616
+12% +$104K 1.24% 29
2024
Q4 		$775K Buy
+263,644
New +$1.08M 0.73% 39

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Monimus Capital Management's TSVT Position: Q2 2025 in Review

Monimus Capital Management sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 296,260 shares — an estimated $1.46M sold.

Monimus Capital Management first reported a position in TSVT in Q4 2024 and held it in 2 quarters. The position peaked at $1.46M in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Monimus Capital Management reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Monimus Capital Management sold 296,260 2seventy bio shares in Q2 2025, an estimated $1.46M.
  • Monimus Capital Management first reported a position in 2seventy bio in Q4 2024 and held it in 2 quarters.
  • Monimus Capital Management's 2seventy bio position peaked at $1.46M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Monimus Capital Management's 13F filing for Q2 2025, filed 15 Aug 2025.